GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19 - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Annales de Cardiologie et d'Angéiologie Année : 2022

GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19

Résumé

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Dates et versions

hal-03822719 , version 1 (24-10-2022)

Identifiants

Citer

Luc Rochette, Geoffrey Dogon, Eve Rigal, Marianne Zeller, Catherine Vergely, et al.. GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19. Annales de Cardiologie et d'Angéiologie, 2022, ⟨10.1016/j.ancard.2022.09.001⟩. ⟨hal-03822719⟩
20 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More